Tyrian Diagnostics Ltd. announced earnings results for the full year ended June 30, 2019. For the full year, the company announced total revenue was AUD 7.346 million compared to AUD 13.036 million a year ago. Net loss was AUD 5.209 million compared to net income of AUD 3.462 million a year ago. Basic loss per share was AUD 0.1095 compared to basic earnings per share of AUD 0.088 a year ago. Diluted loss per share was AUD 0.1095 compared to diluted earnings per share of AUD 0.083 a year ago.